How to Tell Biotech’s Likely Winners From Losers
Wall Street Journal
A discerning approach is warranted even as Merck lifts the sector with a deal for a company without any approved products.
https://www.wsj.com/articles/how-to-tell-biotechs-likely-winners-from-losers-e4d3636